Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alpha-Synucleinopathy”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Not applicableStudy completedNCT02572713
What this trial is testing

Systemic Synuclein Sampling Study (S4)

Who this might be right for
Parkinson's Disease
Michael J. Fox Foundation for Parkinson's Research 80
Not applicableLooking for participantsNCT04724941
What this trial is testing

Prodromal Alpha-Synuclein Screening in Parkinson's Disease Study

Who this might be right for
Parkinson Disease
University Hospital Schleswig-Holstein 2,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06996652
What this trial is testing

An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

Who this might be right for
REM Sleep Behavior Disorder
Yale University 108
Testing effectiveness (Phase 2)Active Not RecruitingNCT05670782
What this trial is testing

Evaluate Safety and Efficacy of KM-819 in Healthy Adults and Participants with Parkinson's Disease

Who this might be right for
Parkinson Disease
FAScinate Therapeutics Inc. 314
Not applicableLooking for participantsNCT05527067
What this trial is testing

A Registered Cohort Study on α-Synucleinopathy

Who this might be right for
α-synucleinopathy
Fujian Medical University Union Hospital 500
Not applicableUnknownNCT05757804
What this trial is testing

Study of 18F-0502B PET Imaging Targeting α-synuclein in the Diagnosis of α-synuclein-related Diseases

Who this might be right for
Positron-Emission TomographyAlpha Synuclein Pathology
Huashan Hospital 20
Not applicableStudy completedNCT05403788
What this trial is testing

Usability Study of a Neuropsychological Intervention Program Based on Virtual Reality in Adults With Parkinson's Disease

Who this might be right for
Parkinson Disease
Corporación de Rehabilitación Club de Leones Cruz del Sur 9
Early research (Phase 1)Study completedNCT04273932
What this trial is testing

Effects of Lithium Therapy on Blood-based Therapeutic Targets in Parkinson's Disease.

Who this might be right for
Parkinson Disease
State University of New York at Buffalo 19
Not applicableStudy completedNCT03363724
What this trial is testing

Validation of HaGuide Software Module Accuracy in Mapping STN Boundaries in Parkinson's Disease Patients Who Underwent DBS Procedure

Who this might be right for
Parkinson DiseaseDeep Brain Stimulation
Alpha Omega Engineering Ltd. 103
Not applicableUnknownNCT01876459
What this trial is testing

Alpha-synuclein in Cerebrospinal Fluid to Differentiate Alzheimer's Disease From Lewy Body Disease.

Who this might be right for
"Alzheimer's Disease" and "Lewy Body Disease"
University Hospital, Strasbourg, France 265
Not applicableStudy completedNCT03595475
What this trial is testing

Prodromal Markers of First-degree Relatives of Patients With Psychiatric Disorders Comorbid With RBD

Who this might be right for
REM Sleep Behavior Disorder
Chinese University of Hong Kong 408
Not applicableStudy completedNCT05188105
What this trial is testing

Alpha tACS in Dementia With Lewy Bodies

Who this might be right for
Dementia With Lewy BodiesLewy Body Disease
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07589595
What this trial is testing

Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Who this might be right for
Cognitive DysfunctionLewy Body DiseaseSynucleinopathies+1 more
Eli Lilly and Company 350
Not applicableUnknownNCT04878679
What this trial is testing

Effect of WB-EMS on Parkinson's Disease

Who this might be right for
Parkinson Disease
Università degli studi di Roma Foro Italico 36
Very early researchLooking for participantsNCT07348250
What this trial is testing

Open-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease

Who this might be right for
Parkinson's Disease (PD)Parkinson's DiseaseParkinson's Disease (Disorder)
Invicro 22
Not applicableStudy completedNCT03170063
What this trial is testing

FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)

Who this might be right for
Parkinson Disease
Michael J. Fox Foundation for Parkinson's Research 54
Not applicableLooking for participantsNCT07533799
What this trial is testing

The Swedish BioFINDER Sleep Study

Who this might be right for
Parkinson´s DiseaseREM Sleep Behavior Disorder (iRBD)Lewy Body Disease+2 more
Skane University Hospital 650
Not applicableLooking for participantsNCT04250493
What this trial is testing

Insulin Resistance in Multiple System Atrophy

Who this might be right for
Multiple System Atrophy
University Hospital, Bordeaux 124
Not applicableUnknownNCT05353868
What this trial is testing

Gut Microbiota in the Progression of Alpha-synucleinopathies

Who this might be right for
REM Sleep Behavior Disorder
Chinese University of Hong Kong 490
Early research (Phase 1)Study completedNCT02046434
What this trial is testing

Phenylbutyrate Response as a Biomarker for Alpha-synuclein Clearance From the Brain

Who this might be right for
Parkinson's Disease
University of Colorado, Denver 38
Load More Results